PharmEnable
PharmEnable Therapeutics is a biopharmaceutical company leveraging AI to create small molecule therapeutics for previously inaccessible drug targets. Their proprietary AI-driven platform, chemSEEK, enables the discovery of novel small molecules with high specificity, aiming to match the precision of biologics. The company focuses on developing treatments for cancer and neurological diseases, and also forms strategic partnerships for drug discovery in challenging therapeutic areas. Originating as a spin-out from the University of Cambridge, UK, PharmEnable's team comprises world-class scientists and business leaders dedicated to innovation, ambition, collaboration, excellence, and integrity.
PharmEnable
PharmEnable Therapeutics is a biopharmaceutical company leveraging AI to create small molecule therapeutics for previously inaccessible drug targets. Their proprietary AI-driven platform, chemSEEK, enables the discovery of novel small molecules with high specificity, aiming to match the precision of biologics. The company focuses on developing treatments for cancer and neurological diseases, and also forms strategic partnerships for drug discovery in challenging therapeutic areas. Originating as a spin-out from the University of Cambridge, UK, PharmEnable's team comprises world-class scientists and business leaders dedicated to innovation, ambition, collaboration, excellence, and integrity.